Literature DB >> 32642757

A Confirmed Case of SARS-CoV-2 Pneumonia With Negative Routine Reverse Transcriptase-Polymerase Chain Reaction and Virus Variation in Guangzhou, China.

Zhengtu Li1, Yinhu Li2, Lingdan Chen1, Shaoqiang Li1, Le Yu2, Airu Zhu1, Feng Yang1, Qian Jiang1, Liyan Chen1, Jincun Zhao1, Wenju Lu1, Nanshan Zhong1, Feng Ye1.   

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia is a newly recognized disease, and its diagnosis is primarily confirmed by routine reverse transcriptase -polymerase chain reaction (RT-PCR) detection of SARS-CoV-2.
METHODS: However, we report a confirmed case of SARS-CoV-2 pneumonia with a negative routine RT-PCR.
RESULTS: This case was finally diagnosed by nanopore sequencing combined with antibody of SARS-CoV-2. Simultaneously, the ORF and NP gene variations of SARS-CoV-2 were found.
CONCLUSIONS: This case highlighted that false-negative results could be present in routine RT-PCR diagnosis, especially with virus variation. Currently, nanopore pathogen sequencing and antibody detection have been found to be effective in clinical diagnosis.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  SARS-CoV-2; nanopore sequencing; pneumonia; routine RT-PCR; virus variation

Mesh:

Substances:

Year:  2021        PMID: 32642757      PMCID: PMC7454436          DOI: 10.1093/cid/ciaa941

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

Review 1.  Strategies and Advances in Combating COVID-19 in China.

Authors:  Wei Liu; Wei-Jie Guan; Nan-Shan Zhong
Journal:  Engineering (Beijing)       Date:  2020-10-15       Impact factor: 7.553

2.  Exploring the Bridge Cases' Role in the Transmission of the SARS-CoV-2 Delta Variant - Ruili City, Yunnan Province, China, July-September 2021.

Authors:  Xiangyu Yan; Litao Chang; Zekun Wang; Linhui Hao; Zhongwei Jia; Bo Zhang; Tiejun Shui
Journal:  China CDC Wkly       Date:  2021-12-03

3.  Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay.

Authors:  Stephanie Popping; Richard Molenkamp; Joachim D Weigel; Pim G N J Mutsaers; Jolanda C Voermans; Sander van Boheemen; Marc C Shamier; Reina S Sikkema; David F Nieuwenhuijse; Bas B Oude Munnink; Marion P G Koopmans; Jeroen J A van Kampen
Journal:  J Virol Methods       Date:  2021-12-01       Impact factor: 2.014

4.  Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing.

Authors:  Yanan Wang; Duo Chen; Chaofeng Zhu; Zhenhua Zhao; Shanshan Gao; Jianjun Gou; Yongjun Guo; Xiangdong Kong
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

5.  Assessment of 12 qualitative RT-PCR commercial kits for the detection of SARS-CoV-2.

Authors:  Asmaa M Altamimi; Dalia A Obeid; Taghreed A Alaifan; Moroje T Taha; Marwa T Alhothali; Fahad A Alzahrani; Ahmad M Albarrag
Journal:  J Med Virol       Date:  2021-03-17       Impact factor: 20.693

6.  Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.

Authors:  Ki Ho Hong; Ji Won In; Jaehyeon Lee; So Yeon Kim; Kyoung Ah Lee; Seunghyun Kim; Yeoungim An; Donggeun Lee; Heungsup Sung; Jae-Seok Kim; Hyukmin Lee
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.